Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Prof. Wee Joo Chng, PhD, of the Yong Loo Lin School of Medicine, National University of Singapore, Singapore describes how genomic technologies can predict patient response to treatment, and how advances in understanding will change the approach to clinical practice. This was interview was recorded at the International Myeloma Workshop (IMW) 2019, in Boston, MA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.